Switching gears along the Yarra River, I pedal faster and faster, heading nowhere in particular. My face just crashed into a party of flies and now I’m swallowing wings. Sinking into my surroundings — the wind, ripples in the water, parrots overhead — with no thoughts of all the elses and elsewheres I could be, I’m tripping.
This microdose feels like a half tab. Which isn’t necessarily bad, except I can’t focus. I can’t sit still. I can’t read the lines of a book without being bombarded by my own. I can’t write. All I can do is keep going and going. Moving through. This is not what I anticipated for a Wednesday morning. Continue reading “Why I quit microdosing”
Will off-label psychedelic prescription use be the new recreational or will it mostly be sought for self-directed therapy or therapy with the help of alternative facilitators? Will people—with or without diagnosable mental conditions—prefer off-label use so they can direct/choose the therapeutic style?*
In response to this recent article in Scientific American.